Pasireotide in Patients With Acromegaly Inadequately Controlled With First Generation Somatostatin Analogues
Clinical trial NCT02354508 · COMPLETED
Trial details
- NCT number
- NCT02354508
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-03-31
- Primary completion
- 2018-01-08
- Enrollment
- 123
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.